Supernus Pharmaceuticals (SUPN) EPS (Basic) (QoQ) (2011 - 2025)
Supernus Pharmaceuticals (SUPN) EPS (Basic) (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.37 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 90.89% |
| Sep 30, 2025 | -298.66% |
| Jun 30, 2025 | 289.69% |
| Mar 31, 2025 | -176.10% |
| Dec 31, 2024 | -60.20% |
| Sep 30, 2024 | 93.06% |
| Jun 30, 2024 | 13,772.67% |
| Mar 31, 2024 | -87.89% |
| Dec 31, 2023 | 107.36% |
| Sep 30, 2023 | -1,828.05% |
| Jun 30, 2023 | -104.87% |
| Mar 31, 2023 | -34.43% |
| Dec 31, 2022 | 1,361.82% |
| Sep 30, 2022 | -77.91% |
| Jun 30, 2022 | -69.36% |
| Mar 31, 2022 | 944.71% |
| Dec 31, 2021 | -88.66% |
| Sep 30, 2021 | -9.43% |
| Jun 30, 2021 | 316.07% |
| Mar 31, 2021 | -81.60% |